Dupuytren’s Contracture Market 2022 Industrial Chain, Regional Scope, Key Players Profiles and Sales Data to 2030
.jpg){kind=logo}
Dupuytren’s Contracture Market Overview
The Dupuytren’s Contracture Market
is anticipated to reach USD 5,900 Million by 2030 at 4.9% CAGR during the
forecast period 2022-2030
Dupuytren’s contracture is a condition primarily of the fingers of
the hand in which there is difficulty in articulating fingers due to formation
of knots of tissue form under the skin which may worsen to a degree that
fingers become permanently bent in a flexed position. The exact causes of
Dupuytren’s contracture are unknown however the risk factors include
alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand
trauma, epilepsy, family history etc. Dupuytren’s contracture has a higher rate
in males over the age of 50. There is also a genetic propensity with Caucasians
being affected more while it is rare among Asians and Africans. Dupuytren’s
contracture has a regress rate of approximately 10 % of patients. The annual
incidence proportion of this disease was estimated at about 3 cases per 10,000
adults. The occurrence rate in the United States is about 5% of people, while
Scandinavian nations has a higher rate of about 30% of men over 60 years old
have the condition.
Needle aponeurotomy (NA) is the preferred surgical treatment of
choice and used in the majority of patients. It is less invasive than the open
hand surgery which is now reserved for the most severe conditions. The
collagenase injection segment is however expected to grow the fastest due to
minimum invasive nature and the lesser hospitalization stay.
The market drivers for Dupuytren’s
Contracture Market are increasing cardiac cases such as heart
attack, other factors includes cancer, kidney failure, end-stage lung cancer,
hypothyroidism, rising screening and penetration of healthcare, growing
awareness about cardiac diseases and growing income and healthcare expenditure
etc. The market restraints are cost of Dupuytren’s contracture surgery,
complications and risk of the surgery, invasive nature of treatment etc.
Dupuytren’s Contracture Market Segmentation
Segmentation
The global Dupuytren’s contracture market has been
segmented on the basis of types, diagnosis, surgery, drugs, therapy and end
users.
Based on type, the market has been segmented as
type I, type II, type III.
Based on diagnosis, the market has been segmented
as physical examination, x-ray and others.
Based on drug, the market has been segmented as
steroids, collagenase injection, immune-modulators and others.
Based on therapy, the market has been segmented as
radiation therapy, physiotherapy and others.
Based on the end user, the market has been
segmented as hospitals clinics, academic and research and others.
Dupuytren’s Contracture Market Regional Analysis
Europe account for a significant market share owing
to extensive use of medications and high expenditure on the health care.
Additionally, the greater prevalence of Dupuytren’s contracture in Europe
drives the Dupuytren’s contracture market. Also, concentration of major
research companies in the developed countries of this region is adding fuel to
the market growth. The highly developed healthcare system of the Scandavanian
region coupled with high expenditure on healthcare, cruises the sale of
Dupuytren’s contracture treatment. Europe is led by countries such as Germany
and France. Norway is expected to be the fastest growing market.
US is the second largest market in the world due to
high income and healthcare penetration. The presence of large healthcare
players in the US benefits the market coupled with the high public expenditure
on healthcare which comes to be approximately 16 % of the GDP. Asia Pacific
region is expected to grow at a slower rate with China and India are likely to
lead this market due to fast growing healthcare sector during the forecast
period. The lower prevalence of Dupuytren’s contracture in the Asian
populations acts as a drag on the market.
Gulf nations such as Saudi Arabia and the UAE are
estimated to drive the Middle East African market. The development of large
hospitals such as the King Fahd hospital in Riyadh is driving the market. The
African region is expected to witness a moderate growth owing to poor economic
and political conditions and poor healthcare development. Also the lower prevalence
of Dupuytren’s contracture in the Asian populations acts as a drag on the
market.
Global Dupuytren’s contracture Market Players
Dupuytren’s
contracture Market Players include Bristol-Meyers Squibb Co, Fresenius Kabi,
Merck Company, Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmacueticals,
Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co.,
Ltd., Endo International plc. Pfizer Inc., and others.
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment